report_id,intake_method,report_date,event_date,report_type,outcome,patient_age,patient_sex,weight_kg,ethnicity,race,description,suspect_product_name,dose,frequency,route,start_date,stop_date,indication,reporter_profession,report_source,manufacturer_name,report_sent_to_FDA
AEV-00001,Phone,2025-07-15,2025-07-10,['Adverse Event'],"['Hospitalization', 'Life-threatening']",67,Male,72.5,Not Hispanic/Latino,['White'],Patient developed severe rash and shortness of breath after 3 days on DrugA.,DrugA,500,Twice a day,Oral,2025-07-01,2025-07-10,Hypertension,Nurse,['Health Professional'],PharmaCo Inc.,Yes
